In general— Not later than 15 days after the date of the enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall implement a process under which the Secretary may issue waivers, with respect to an infant formula that is available for commercial use in the European Union, of the requirements of sections 412 and 415 of the Federal Food, Drug, and Cosmetic Act (
21 U.S.C. 350a; 350d), and other applicable requirements of such Act, as appropriate, in order to allow for the introduction into interstate commerce of such infant formula in the United States.